HLA-A and pancreatic neoplasm: Importantly, our identified HLA-A*11:01–restricted mutant KRAS G12V8–16–reactive TCR–transduced T cells could specifically recognize all tested human pancreatic cancer organoids that expressed HLA-A*11:01 and KRAS G12V, but only killed some of them.